Swedbank Ab Maxcyte, Inc. Transaction History
Swedbank Ab
- $79.2 Billion
- Q4 2024
A detailed history of Swedbank Ab transactions in Maxcyte, Inc. stock. As of the latest transaction made, Swedbank Ab holds 1,600,000 shares of MXCT stock, worth $3.52 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,600,000Holding current value
$3.52 Million% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
73.2MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$22.1 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$17.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12.2 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$11.1 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $224M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...